'Tuberculin skin' presentation slideshows

Pediatric Tuberculosis Update

Pediatric Tuberculosis Update . Dr. George McSherry. Audio Conference July 27, 2005. Tuberculosis in Children and Adolescents 2005. Epidemiology Public Health Aspects & TB Control Targeted Tuberculin Skin Testing Contact Investigations BCG Vaccine

800 views • 57 slides

Hepatology Board Review

Hepatology Board Review. Scott Gabbard, MD 06/09/2009. Question 1.

829 views • 44 slides

The Role of Laboratories in Surveillance

The Role of Laboratories in Surveillance. Mahon 2006 Arnold Bosman Source: WHO-Lyon, Julia Fitzner, 2004. The role of the Laboratory . Identification and characterisation of pathogens Confirm diagnosis to support case management Identification of subtypes, typing Public health added value

631 views • 42 slides

R espiratory block TUBERCULOSIS

Pathology L5. R espiratory block TUBERCULOSIS. Dr. Maha Arafah Associate Professor in Pathology Office phone number: - 01-4671067 Available office hours for students: 10 till 12 daily. Feb, 2013. OBJECTIVES AND KEY PRINCIPLES TO BE TAUGHT: Define tuberculosis.

747 views • 42 slides

Epidemiology Tools and Methods

Epidemiology Tools and Methods. Session 2, Part 1. Learning Objectives Session 2, Part 1. List methods that can be used for epidemiologic assessment of a health problem Identify ways that public health laboratories carry out epidemiologic functions

706 views • 32 slides

Immunology of Tuberculosis

Immunology of Tuberculosis. Immunology Unit Department of Pathology. Objectives. To know how M. tuberculosis infection is contracted and its initial encounter with the immune system. To understand delayed type of hypersensitivity reaction against M. tuberculosis

693 views • 31 slides

Immunization and RSV/Palivizumab Clinic Update

Immunization and RSV/Palivizumab Clinic Update. Advances in preventative care for our pediatric population. Immunization Update. The ever changing quagmire of pediatric immunization schedules

763 views • 30 slides

Case discussion

Case discussion. Michael Gardam University Health Network. Do you have any cases you would like to discuss?. Case 1. 53 year old male presents with a 6 week history of cough, worsening malaise, weight loss, maybe low grade fever CXR shows a right upper lobe infiltrate.

366 views • 26 slides

Tuberculin skin Testing Mantoux tuberculin skin test

Tuberculin skin Testing Mantoux tuberculin skin test. Dr.T.V.Rao MD. Tuberculosis: PRIMARY Infection. 95% of cases begin with pulmonary focus usually a SINGLE focus hypersensitivity develops 2 to 6 weeks until then, focus may grow larger hypersensitivity brings caseation.

2.49k views • 25 slides

Darlene Morse, RN, M. Ed., CHES, CIC Public Health Nurse Program Manager

Darlene Morse, RN, M. Ed., CHES, CIC Public Health Nurse Program Manager Bureau of Infectious Disease Control Division of Public Health Services. TB Testing Current Thinking. History of Mantoux Skin Testing. Originally developed by Dr. Robert Koch in 1890 What else was he known for?

447 views • 20 slides

Lymphadenopathy

Lymphadenopathy. M.JARI.MD. Objectives. Define lymphadenopathy Develop a systematic approach to the evaluation and management of lymphadenopathy Discuss the differential diagnosis of localize and generalized lymphadenopathy. Lymphatic System. Lymphtic system. Lymph nodes

1.39k views • 17 slides

Taiwan Tuberculosis Symposium

Taiwan Tuberculosis Symposium. Nov.30-Dec.1, 2005. Taipei International Convention Center. Welcome Address. Dear Colleagues, We warmly welcome you to the Taiwan Tuberculosis Symposium.

373 views • 17 slides

343 views • 16 slides

Chapter 86

Chapter 86. Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infections. Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infections. Tuberculosis Mycobacterium tuberculosis Person to person

375 views • 12 slides

IGRAs: Should they replace the TST in the identification of latent tuberculosis?

186 views • 5 slides

Prevention

Prevention. Bacille Calmette Guerin (BCG) Vaccine Live attenuated strain of Mycobacterium bovis ; 1921 Efficacy Clinical trials UK: protective effect of 60 to 80%; Trials elsewhere have shown variable results; efficacy ? the closer one gets to the equator

209 views • 5 slides